BROOKSTONE CAPITAL MANAGEMENT ARK Genomic Revolution ETF Transaction History

BROOKSTONE CAPITAL MANAGEMENT portfolio value:

$4.75M
portfolio value

BROOKSTONE CAPITAL MANAGEMENT quarter portfolio value change:

+4.38%
quarter

ARK Genomic Revolution ETF 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -12.87% -22.00K shares -1.65M $32.87 148.97K
Q2 2022 share Increase +4.08% 6.69K shares -605K $31.49 170.97K
Q1 2022 share Decrease -10.73% -19.75K shares -2.97M $45.93 164.27K
Q4 2021 share Decrease -7.45% -14.80K shares -4.66M $62.19 184.02K
Q3 2021 share Decrease -4.11% -8.51K shares -3.26M $74.72 198.83K
Q2 2021 share Increase +2.96% 5.95K shares 42K $92.5 207.34K
Q1 2021 share Increase +30.49% 47.05K shares 3.47M $88.73 201.38K
Q4 2020 share Increase +41.97% 45.62K shares 7.46M $93.26 154.33K
Q3 2020 share Increase +79.36% 48.09K shares 3.76M $63.18 108.70K
Q2 2020 share Increase +125.22% 33.69K shares 2.31M $51.73 60.61K
Q1 2020 share Increase +53.07% 9.33K shares 253K $31.02 26.91K
Q4 2019 share Increase +72.46% 7.38K shares 288K $33.24 17.58K
Q3 2019 share Increase 0.00% 10.19K shares 301K $28.4 10.19K
Q4 2018 share Decrease -100.00% -27.50K shares -919K $23.07 0
Q3 2018 share Increase 0.00% 27.50K shares 919K $31.9 27.50K